Published in J Cancer Res Clin Oncol on August 22, 2014
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial. Lancet Oncol (2015) 1.81
Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma. BMC Cancer (2016) 1.41
Management of metastatic malignant thymoma with advanced radiation and chemotherapy techniques: report of a rare case. World J Surg Oncol (2015) 0.79
Efficacy and safety of the combination of paclitaxel and platinum in advanced thymic carcinoma. Thorac Cancer (2015) 0.75
Isolated splenic metastasis from a thymic carcinoma: A case report. Cancer Biol Ther (2016) 0.75
Adjuvant Therapy for Thymic Carcinoma - A Decade of Experience in a Taiwan National Teaching Hospital. PLoS One (2016) 0.75
Metronomics for thymic carcinoma. Ecancermedicalscience (2014) 0.75
Gemcitabine in patients previously treated with platinum-containing chemotherapy for refractory thymic carcinoma: radiographic assessment using the RECIST criteria and the ITMIG recommendations. Int J Clin Oncol (2015) 0.75
Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med (2002) 7.59
Analysis of survival by tumor response. J Clin Oncol (1983) 5.91
Epidemiology of thymoma and associated malignancies. J Thorac Oncol (2010) 2.52
Thymic hyperplasia and neoplasia: a review of current concepts. Hum Pathol (1978) 2.22
Thymic carcinoma: a multivariate analysis of factors predictive of survival in 290 patients. Ann Thorac Surg (2012) 1.86
Thymoma: a clinicopathologic study. J Thorac Cardiovasc Surg (1961) 1.67
Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol (1994) 1.51
Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer (2004) 1.47
Staging system of thymoma. J Thorac Oncol (2010) 1.45
Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma. J Clin Oncol (2011) 1.40
Standard outcome measures for thymic malignancies. J Thorac Oncol (2010) 1.39
Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy. Eur J Cancer (2008) 1.33
Chemotherapy for invasive thymoma. A 13-year experience. Cancer (1991) 1.28
Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer (2001) 1.28
Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol (1996) 1.27
Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol (1997) 1.26
Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma. Lung Cancer (2009) 1.19
Pathology of thymic epithelial tumors. Curr Top Pathol (1986) 1.19
Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience. Br J Cancer (1999) 1.13
Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg (1993) 1.12
Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylprednisolone. J Thorac Oncol (2007) 1.10
Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma. Cancer (2003) 1.07
Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma. J Thorac Oncol (2011) 1.04
The IASLC/ITMIG thymic malignancies staging project: development of a stage classification for thymic malignancies. J Thorac Oncol (2013) 1.00
Neoadjuvant chemotherapy for stage III and IVA thymomas: a single-institution experience with a long follow-up. J Thorac Oncol (2006) 0.99
Chemotherapy definitions and policies for thymic malignancies. J Thorac Oncol (2011) 0.98
The role of chemotherapy in advanced thymoma. J Thorac Oncol (2010) 0.95
Neuroendocrine differentiation is a common feature of thymic carcinoma. Am J Surg Pathol (1998) 0.93
Multicenter phase II trial assessing effectiveness of imatinib mesylate on relapsed or refractory KIT-positive or PDGFR-positive sarcoma. J Orthop Sci (2010) 0.93
A phase-II trial of dose-dense chemotherapy in patients with disseminated thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9605). Br J Cancer (2009) 0.91
Cisplatin and irinotecan combination chemotherapy for advanced thymic carcinoma: evaluation of efficacy and toxicity. Lung Cancer (2011) 0.89
Outcome of multimodality treatment for 188 cases of type B3 thymoma. J Thorac Oncol (2013) 0.86
Combination chemotherapy with carboplatin and paclitaxel for advanced thymic cancer. Jpn J Clin Oncol (2011) 0.85
Thymic tumours in Denmark. A retrospective study of 213 cases from 1970-1993. Pathol Res Pract (1999) 0.84
A prospective phase II trial of induction chemotherapy with docetaxel/cisplatin for Masaoka stage III/IV thymic epithelial tumors. J Thorac Oncol (2013) 0.83
Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma. A French experience. J Thorac Oncol (2010) 0.83
Messenger RNA and protein expression of thymidylate synthase and DNA repair genes in thymic tumors. Lung Cancer (2012) 0.82
Reproducibility of the WHO classification of thymomas: practical implications. Lung Cancer (2012) 0.80
Guidelines for management of idiopathic normal pressure hydrocephalus: second edition. Neurol Med Chir (Tokyo) (2012) 1.62
A serine palmitoyltransferase inhibitor blocks hepatitis C virus replication in human hepatocytes. Gastroenterology (2013) 1.47
Early embryonic lethality caused by targeted disruption of the mouse PHGPx gene. Biochem Biophys Res Commun (2003) 1.47
Clinical outcomes with chemotherapy for advanced thymic carcinoma. Lung Cancer (2013) 1.10
Characterization of Shiga toxin-producing Escherichia coli O26 strains and establishment of selective isolation media for these strains. J Clin Microbiol (2002) 1.09
Hepatitis C virus impairs p53 via persistent overexpression of 3beta-hydroxysterol Delta24-reductase. J Biol Chem (2009) 1.04
S-1 is an active anticancer agent for advanced thymic carcinoma. Lung Cancer (2010) 1.03
Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review. Breast Cancer (2012) 1.02
Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo. Blood (2010) 1.01
Buckminsterfullerenes: a non-metal system for nitrogen fixation. Nature (2004) 1.00
Lightening effect on ultraviolet-induced pigmentation of guinea pig skin by oral administration of a proanthocyanidin-rich extract from grape seeds. Pigment Cell Res (2003) 1.00
The role of airway stent placement in the management of tracheobronchial stenosis caused by inoperable advanced lung cancer. Surg Today (2010) 0.98
Beneficial effects of grape seed extract on malondialdehyde-modified LDL. J Nutr Sci Vitaminol (Tokyo) (2007) 0.97
In vivo evaluation of a porous hydroxyapatite/poly-DL-lactide composite for use as a bone substitute. J Biomed Mater Res A (2005) 0.96
Serum adiponectin concentrations in newborn infants in early postnatal life. Pediatr Res (2004) 0.94
Right ventricular septal pacing preserves global left ventricular longitudinal function in comparison with apical pacing: analysis of speckle tracking echocardiography. Circ J (2011) 0.94
Choroidal metastasis in a patient with small cell lung cancer discovered during treatment with chemotherapy. Int J Clin Oncol (2009) 0.93
Procyanidin-rich extract from grape seeds prevents cataract formation in hereditary cataractous (ICR/f) rats. J Agric Food Chem (2002) 0.92
Oral intake of soy isoflavone aglycone improves the aged skin of adult women. J Nutr Sci Vitaminol (Tokyo) (2007) 0.92
Microwave coagulation therapy in canine peripheral lung tissue. J Surg Res (2005) 0.92
Cisplatin and irinotecan combination chemotherapy for advanced thymic carcinoma: evaluation of efficacy and toxicity. Lung Cancer (2011) 0.89
Prevention of positive coronary artery remodeling with statin therapy in patients with coronary artery diseases. Angiology (2006) 0.88
Predicting 5-FU sensitivity using human colorectal cancer specimens: comparison of tumor dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activities with in vitro chemosensitivity to 5-FU. Int J Clin Oncol (2002) 0.88
Phase II study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo Cooperative Oncology Group study. Cancer Chemother Pharmacol (2009) 0.87
Eligibility for bevacizumab as an independent prognostic factor for patients with advanced non-squamous non-small cell lung cancer: a retrospective cohort study. PLoS One (2013) 0.87
Antihypertensive and natriuretic effects of less-sodium soy sauce containing gamma-aminobutyric acid in spontaneously hypertensive rats. Biosci Biotechnol Biochem (2007) 0.86
White matter involvement in idiopathic normal pressure hydrocephalus: a voxel-based diffusion tensor imaging study. J Neurol (2011) 0.86
Oral intake of proanthocyanidin-rich extract from grape seeds improves chloasma. Phytother Res (2004) 0.86
Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer. Oncol Rep (2006) 0.85
Moderate physical exercise induces the oxidation of human blood protein thiols. Life Sci (2002) 0.85
Retrospective analysis of efficacy and safety of amrubicin in refractory and relapsed small-cell lung cancer. Int J Clin Oncol (2009) 0.85
Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer. Invest New Drugs (2013) 0.85
Activated charcoal bronchial aspiration. J Bras Pneumol (2012) 0.85
Reduced transcription of the RB2/p130 gene in human lung cancer. Mol Carcinog (2003) 0.83
Pulpal blood flow in vital and nonvital young permanent teeth measured by transmitted-light photoplethysmography: a pilot study. Pediatr Dent (2003) 0.83
Prognostic factors in patients with pathological and N2 non-small cell lung cancer. Ann Thorac Cardiovasc Surg (2008) 0.83
Monoclonal antibody 2-152a suppresses hepatitis C virus infection through betaine/GABA transporter-1. J Infect Dis (2011) 0.83
Systemic versus coronary levels of inflammation in acute coronary syndromes. Angiology (2006) 0.82
D-Amino acid dehydrogenase from Helicobacter pylori NCTC 11637. Amino Acids (2009) 0.82
Impact of type 2 diabetes on serial changes in tissue characteristics of coronary plaques: an integrated backscatter intravascular ultrasound analysis. Eur Heart J Cardiovasc Imaging (2012) 0.81
Bioactive and bioresorbable cellular cubic-composite scaffolds for use in bone reconstruction. J R Soc Interface (2006) 0.81
Identification of the positive regulatory and distinct core regions of promoters, and transcriptional regulation in three types of mouse phospholipid hydroperoxide glutathione peroxidase. J Biochem (2006) 0.81
The promoter region of the human BUBR1 gene and its expression analysis in lung cancer. Lung Cancer (2002) 0.81
Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer. Genes Chromosomes Cancer (2003) 0.81
Reduction in plasma free fatty acid in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 0.80
Comparison of nanohardness between coronal and radicular intertubular dentin. Dent Mater J (2009) 0.80
Quantitative assessment of regional left ventricular wall thickness and thickening using 16 multidetector-row computed tomography: comparison with cine magnetic resonance imaging. Radiat Med (2007) 0.80
Anti-allergic activity of naringenin chalcone from a tomato skin extract. Biosci Biotechnol Biochem (2004) 0.80
Visualization of traumatic tricuspid insufficiency by three-dimensional echocardiography. J Cardiol (2009) 0.80
Endogenous metalloprotease solubilizes IL-13 receptor alpha2 in airway epithelial cells. Biochem Biophys Res Commun (2007) 0.80
[Strontium-89 therapy and subarachnoid phenol block successfully eliminated intractable pain of metastasis in the patient with advanced urachal carcinoma]. Gan To Kagaku Ryoho (2011) 0.80
[Hypercalcemia and multiple osteolytic lesions associated with proinflammatory cytokines in a patient with acute lymphoblastic leukemia]. Rinsho Ketsueki (2007) 0.79
Genomic polymorphisms in 3β-hydroxysterol Δ24-reductase promoter sequences. Microbiol Immunol (2013) 0.79
Impact of septal curvature on regional strain in patients with hypertrophic cardiomyopathy. Circ J (2012) 0.79
[Alveolar hemorrhage as a possible adverse drug reaction by gefitinib (ZD1839, Iressa)]. Gan To Kagaku Ryoho (2003) 0.79
Small-cell lung cancer with a rare epidermal growth factor receptor gene mutation showing "wax-and-wane" transformation. BMC Cancer (2013) 0.78
Surface functionalization of a polymeric lipid bilayer for coupling a model biological membrane with molecules, cells, and microstructures. Langmuir (2013) 0.78
Changes in the volumes of the brain and cerebrospinal fluid spaces after shunt surgery in idiopathic normal-pressure hydrocephalus. J Neurol Sci (2010) 0.78
Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) as measured by redox status of plasma coenzyme Q10. Pathophysiology (2005) 0.78
Clinical outcomes after first-line EGFR inhibitor treatment for patients with NSCLC, EGFR mutation, and poor performance status. Anticancer Res (2013) 0.78
Concomitant chemoradiotherapy and antiretroviral therapy for HIV-infected patients with locoregionally advanced non-small cell lung cancer: benefit and tolerability of treatment in 2 cases. Onkologie (2013) 0.78
Evaluation of a recombinant measles virus expressing hepatitis C virus envelope proteins by infection of human PBL-NOD/Scid/Jak3null mouse. Comp Immunol Microbiol Infect Dis (2010) 0.78
A population-based study of gefitinib in patients with postoperative recurrent non-small cell lung cancer. Exp Ther Med (2011) 0.77
A long-term survival case of small cell lung cancer in an HIV-infected patient. Jpn J Clin Oncol (2005) 0.77
Clinical characteristics of Japanese lung cancer patients with human immunodeficiency virus infection. Int J Clin Oncol (2011) 0.77
Clinicopathological analysis of thymic malignancies with a consistent retrospective database in a single institution: from Tokyo Metropolitan Cancer Center. BMC Cancer (2014) 0.77
Voxel-based morphometry of disproportionate cerebrospinal fluid space distribution for the differential diagnosis of idiopathic normal pressure hydrocephalus. J Neuroimaging (2013) 0.77
Long-term survival following metachronous intratumoral hemorrhage in an HIV-infected patient with lung cancer. Int J Clin Oncol (2010) 0.76
Pharmacogenetic interactions between Angiotensin-converting enzyme insertion/deletion polymorphism and response to cibenzoline in patients with hypertrophic obstructive cardiomyopathy. J Cardiovasc Pharmacol (2010) 0.76
Right ventricular pacing from the septum avoids the acute exacerbation in left ventricular dyssynchrony and torsional behavior seen with pacing from the apex. J Am Soc Echocardiogr (2009) 0.76
Large solid-pseudopapillary neoplasm of the pancreas with aberrant protein expression and mutation of β-catenin: a case report and literature review of the distribution of β-catenin mutation. Intern Med (2013) 0.76
Direct evidence for a hydrogen bond to bound dioxygen in a myoglobin/hemoglobin model system and in cobalt myoglobin by pulse-EPR spectroscopy. Angew Chem Int Ed Engl (2008) 0.76
Significance of the distal to proximal coronary flow velocity ratio by transthoracic Doppler echocardiography for diagnosis of proximal left coronary artery stenosis. J Am Soc Echocardiogr (2007) 0.76
Translocase of outer mitochondrial membrane 70 induces interferon response and is impaired by hepatitis C virus NS3. Virus Res (2011) 0.76
Direct measurement of radial strain in the inner-half layer of the left ventricular wall in hypertensive patients. J Cardiol (2011) 0.76
Reduced transcription of the Smad4 gene during pulmonary carcinogenesis in idiopathic pulmonary fibrosis. Mol Med Rep (2011) 0.76
The Association of Calf Circumference with Resting Pulse Rate in Community-dwelling Healthy Elderly Women -Pilot Study-. J Phys Ther Sci (2013) 0.75
Purification and characterization of serine racemase from a hyperthermophilic archaeon, Pyrobaculum islandicum. J Bacteriol (2007) 0.75
Heterogeneous Intravascular Ultrasound Findings of Stent Thrombosis. Intern Med (2017) 0.75
Role of transthoracic Doppler echocardiography in patients with a proximal left coronary artery lesion that cannot be diagnosed by computed tomography angiography. Am J Cardiol (2013) 0.75
Relation between incremental lines and tensile strength of coronal dentin. Dent Mater J (2012) 0.75
Frequent urination caused by a giant iliac artery aneurysm. J Am Coll Cardiol (2013) 0.75
[Re-treatment with epidermal growth factor receptor tyrosine kinase inhibitor(EGFR-TKI)for lung adenocarcinoma]. Gan To Kagaku Ryoho (2010) 0.75
Leukemic infiltration of the lung following allogeneic hematopoietic stem cell transplantation. Int J Hematol (2008) 0.75
Phase I/II study of paclitaxel + carboplatin for refractory or recurrent non-small cell lung cancer. Anticancer Res (2006) 0.75
Acute effects of adaptive servo ventilation on hemodynamics, coronary flow, and flow reserve in a patient with idiopathic dilated cardiomyopathy. Can J Cardiol (2012) 0.75
Serum dipeptidyl peptidase 4 activity in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab (2013) 0.75
[A case of pulmonary MALT lymphoma with multiple nodules and ground-glass opacities]. Nihon Kokyuki Gakkai Zasshi (2011) 0.75